New Partner for the Swiss Cannabis Market
The Swiss pharmaceutical distributor Astrasana has reached a significant agreement. The company has secured exclusive distribution rights for the genetics of the Canadian cannabis producer Green Karat in Switzerland.
Through this collaboration, Astrasana gains direct access to high-quality cannabis strains from Canada. These genetic resources are now to be specifically utilized in the Swiss market to expand the range of medical cannabis products.
The partnership is an important step for the growing Swiss medical cannabis market. With these new products, Astrasana aims to improve the care of patients who rely on controlled and high-quality treatment.
The exact details regarding implementation and the start of distribution have not yet been made public. However, experts observe that the Swiss market is increasingly gaining professionalism through such international collaborations.
In summary, this deal strengthens Astrasana's position in the industry. For Swiss patients, this could mean better access to specialized cannabis strains in the future.